TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,839.38−0.21%FTSE ADX9,860.79+0.79%TASI10,123.62−0.65%QE Index8,587.83−0.52%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,973.30+0.00%DFM:EMIRATESNBDAED 31.50+0.00%ADX:IHCAED 359.40+2.10%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.50−1.02%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,132.22−0.21%Brent$110.00+0.72%BTC$81,679.41−0.20%ETH$2,393.22−0.50%DFM General5,839.38−0.21%FTSE ADX9,860.79+0.79%TASI10,123.62−0.65%QE Index8,587.83−0.52%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,973.30+0.00%DFM:EMIRATESNBDAED 31.50+0.00%ADX:IHCAED 359.40+2.10%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.50−1.02%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,132.22−0.21%Brent$110.00+0.72%BTC$81,679.41−0.20%ETH$2,393.22−0.50%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralOpen 🇸🇦Saudi ArabiaTadawul · TASIOpen 🇶🇦QatarQSE · QE GeneralOpen 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Biohaven Ltd · Overview · TradingHolo

Markets › United States › NYSE › BHVN

B

Biohaven Ltd

NYSE:BHVNHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$10.78−5.69%At closeAt close · Sat 17 Oct · ≈ AED 39.59 · Market cap $1.63B · Next earnings Mon 9 Nov · Extended $10.89 +1.02%

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−5.7%

1M

−22.4%

3M

−27.5%

6M

−1.8%

1Y

−37.9%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

BHVN −5.69% today

✦ This week in three lines

No written digest yet for BHVN. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector−2.2× vs −1.7×

Price / Book vs sector31.3× vs 2.0×

Price / Sales vs sector—

Price / Free cash flow vs sector−2.7× vs −1.6×

Forecasts

10 buy3 hold1 sell14 analysts

Average target$19.00 +76.3%

Analysts1

EPS surprises, last 82 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All BHVN news →

TRBiohaven Licenses IgG Degrader Portfolio to Ono Pharmaceutical for $80M Upfront, 20% Royalties

TradingView · 4 d ago

SEBiohaven licenses IgG degrader portfolio to Japan’s Ono

Seeking Alpha · 12 d ago

REBiohaven Enters Strategic Licensing Agreement With Ono Pharma

Reuters · 12 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$1.63B

P/E−2.2×

Dividend yield0.0%

52-week range$7.48 – $18.57

Avg volume (20d)2,098,958

Shares outstanding151,043,780

Beta3.16

Short interest14.8% of float

Next earningsMon 9 Nov

Radar Score

26

Value17

Quality1

Momentum40

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.

SectorHealthcare

IndustryNormal

ExchangeNYSE

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%